Skip to main content
. Author manuscript; available in PMC: 2016 Jul 7.
Published in final edited form as: J Med Chem. 2015 Sep 11;58(18):7603–7608. doi: 10.1021/acs.jmedchem.5b00935

Table 1.

Infection inhibition against Bal.01 and JR-FL HIV-1 pseudoviruses exhibited by the parent lead peptide 1 and three cPTs, 4, 7 and 9.

Compound BaL.01 inhibition IC50 (nM) JR-FL inhibition IC50 (nM)
1 850 ± 136 453 ± 137
4 650 ± 70 603 ± 98
7 2018 ± 95 2330 ± 538
9 210 ± 12 190 ± 34